Projects per year
Personal profile
Biography
I am Pharmacologist interested in analgesics and other psychoactive drugs, particularly cannabinoids and opioids. My lab studies how opioids, cannabinoids and related molecules interact with G protein coupled receptors and ion channels to exert their effects. Currently my work is focussed on how clinically used opioids interact with naturally occuring variants of human opioid receptors, the pharmacology and toxicity of emerging synthetic cannabinoid receptors agonists (Spice/K2) and the molecular mechanisms underlying the potential therapeutic actions of cannabis and its components.
Education/Academic qualification
Pharmacology, PhD, University of Washington
Pharmacology, Genetics, BSc (Hons), University of Sydney
Fingerprint Dive into the research topics where Mark Connor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
mu Opioid Receptor
Medicine & Life Sciences
Opioid Analgesics
Medicine & Life Sciences
Cannabinoids
Chemical Compounds
Pharmacology
Medicine & Life Sciences
Neurons
Medicine & Life Sciences
Periaqueductal Gray
Medicine & Life Sciences
Cannabinoid Receptor CB2
Medicine & Life Sciences
Cannabinoid Receptor Agonists
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2019
Establishment of archival freezer storage bay
Chung, R., Atkin, J., Connor, M., Blair, I., Rizos, H., Phillips, J. & Laird, A.
1/01/19 → 31/12/19
Project: Research
High-content screening platform
Atkin, J., Connor, M., Blair, I., Rizos, H., Phillips, J. & Laird, A.
1/01/19 → 31/12/19
Project: Research
Development of next-generation targeted therapies for epilepsy and pain based on cannabinoid derivatives
Bladen, C. & Connor, M.
3/07/17 → …
Project: Research
Advanced protein quantification capability
Walker, A., Lee, A., Connor, M., Atkin, J., Lim, C., Baker, M., Rizos, H., Phillips, J., Yang, S. & Blair, I.
1/01/17 → …
Project: Research
Mechanisms underlying the repellent effects of predator odours in rodents
Connor, M., McGregor, I., Crowther, M. & Banister, S.
1/01/16 → …
Project: Research
Research Outputs 1991 2019
Cannabichromene is a Cannabinoid CB2 receptor agonist
Udoh, M., Santiago, M., Devenish, S., McGregor, I. & Connor, M., 1 Aug 2019, (Accepted/In press) In : British Journal of Pharmacology.Research output: Contribution to journal › Article › Research › peer-review
Cannabinoid Receptor Agonists
Cannabinoid Receptor CB2
Cannabinoid Receptor CB1
Dronabinol
Cell Surface Receptors
Dark classics in Chemical Neuroscience: Δ 9 -tetrahydrocannabinol
Banister, S. D., Arnold, J. C., Connor, M., Glass, M. & Mcgregor, I. S., 15 May 2019, In : ACS Chemical Neuroscience. 10, 5, p. 2160-2175 16 p.Research output: Contribution to journal › Review article › Research › peer-review
Dronabinol
Neurosciences
Cannabis
Medical Marijuana
Pharmacology
New-generation azaindole-adamantyl-derived synthetic cannabinoids
Longworth, M., Reekie, T. A., Blakey, K., Boyd, R., Connor, M. & Kassiou, M., Jul 2019, In : Forensic Toxicology. 37, 2, p. 350-365 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Cannabinoids
Ionization
Mass spectrometry
Assays
Mass Spectrometry
Regulation of heterologously expressed 5-HT1B receptors coupling to potassium channels in AtT-20 cells
Heblinski, M., Bladen, C. & Connor, M., 1 Feb 2019, In : British Journal of Pharmacology. 176, 3, p. 451-465 15 p.Research output: Contribution to journal › Article › Research › peer-review
Receptor, Serotonin, 5-HT1B
Potassium Channels
Sumatriptan
Serotonin
G Protein-Coupled Inwardly-Rectifying Potassium Channels
Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids
Moir, M., Lane, S., Lai, F., Connor, M., Hibbs, D. E. & Kassiou, M., 15 Oct 2019, In : European Journal of Medicinal Chemistry. 180, p. 291-309 19 p.Research output: Contribution to journal › Article › Research › peer-review
Cannabinoid Receptor CB2
Cannabinoids
Chemical activation
Designer Drugs
Cannabinoid Receptor CB1